Just to “close” the intel­lec­tu­al (as well as finan­cial) posi­tion we opened on March 24, 2020, for the record, we here­with state that we con­sid­er the stock mar­ket ral­ly that com­menced on this day to have log­i­cal­ly run its course. We have now begun tak­ing posi­tions in select­ed finan­cial instru­ments bet­ting that the stock mar­ket will fall from here, and very sig­nif­i­cant­ly so. 
Logic is all about relat­ing indi­vid­ual pieces of infor­ma­tion in a con­sis­tent way. “Consistent” means non-con­tra­dic­to­ry. An appar­ent ten­den­cy of two pieces of infor­ma­tion to appear incon­sis­tent calls for express dif­fer­en­ti­at­ing clar­i­fi­ca­tion, with the log­i­cal­ly required depth of dif­fer­en­ti­at­ing dis­cus­sion depend­ing on the extent to which both pieces of infor­ma­tion appear similar. 
While we are cur­rent­ly work­ing on oth­er urgent mat­ters and have hard­ly any time to fol­low up on the the throat dis­in­fec­tion com­plex, let us – very briefly – make the fol­low­ing addi­tion­al com­ments with regard to the study under­way in Kentucky. If noth­ing else, they may serve as a men­tal check to the study inves­ti­ga­tors (who we will make aware of them, of course). 
A group of researchers from the UK (Cardiff and Cambridge), the US (Denver, Colorado), Spain (Barcelona), and Canada (Ottawa) has now picked up the idea we have put for­ward almost exact­ly two months ago for pre­ven­tive throat dis­in­fec­tion with viru­ci­dal agents that are known to be effec­tive against coro­n­avirus­es and safe to use in the throat. The WHO should now even more seri­ous­ly con­sid­er includ­ing it in its recommendations. 
COVID-19, many believe, has thrown the world into unprece­dent­ed dis­as­ter, and to those believ­ing so, the future looks bleak at best. But what if the oppo­site will prove to be true? Speculation is a noble occu­pa­tion, futures stud­ies an aca­d­e­m­ic dis­ci­pline, so we haz­ard a brief pre­view of the enor­mous eco­nom­ic and soci­etal gains for which the COVID-19 cri­sis may have just sown the seeds. 
While in recent weeks we have been focused on estab­lish­ing and com­pre­hend­ing as deeply as pos­si­ble the immuno­log­i­cal “big pic­ture” in viral epi­demics from so far only part­ly inter­con­nect­ed evi­dence in the spe­cial­ist lit­er­a­ture, in order to derive action­able rec­om­men­da­tions, we briefly sum­ma­rize what has emerged in terms of feed­back as well as addi­tion­al insight with regard to our first arti­cle since it appeared.